COPENHAGEN (Reuters) - Shares in Danish cannabis firm StenoCare more than tripled in value in their debut on Friday.
Shares were priced at 8.80 Danish crowns ($1.34) in the initial public offering on the Danish-Swedish Spotlight exchange and rose to as much as 33.50 crowns in early trading.
At 0721 GMT the stock was trading at 29.15 crowns.
Scientists say evidence is growing that cannabis can ease epilepsy and other conditions such as chronic pain, multiple sclerosis and chemotherapy-induced nausea, prompting renewed interest in a substance best known for its psychoactive properties.
StenoCare plans to use the money to launch its own production facility to serve local customers and to export to other European markets. ($1 = 6.5540 Danish crowns)
(Reporting by Jacob Gronholt-Pedersen; Editing by Robin Pomeroy)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app